Frank Karbe, Director: Phathom Pharmaceuticals PHAT Buy · Filed 24/12/16

Trade details

Type: Insider buy
Amount: $99,125
Shares · price: 12,500 sh · $7.93 a share
Held after: 57,000 sh
Stock: Phathom Pharmaceuticals PHAT
Person: Frank KarbeDirector
Trade date: 24/12/13
Filed: 24/12/16
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +28.1%

Phathom Pharmaceuticals trades, last 26 weeks

What else happened in Phathom Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/11/13~25/01/12

Frank Karbe's recent trades

Frank KarbeCEO
BuyBetter Therapeutics
Buy
Better Therapeutics
BTTX
$100K
137,005 sh
$100K
Filed 23/07/31
Traded 23/07/27
Frank KarbeSEE REMARKS
BuyBetter Therapeutics
Buy
Better Therapeutics
BTTX
$201.2K
242,424 sh
$201.2K
Filed 23/04/12
Traded 23/04/10